Drug‐Coated Balloons Versus Non‐Coated Balloons for Side Branch Treatment in Bifurcation Lesions: A Systematic Review and Meta‐Analysis
Catheterization and Cardiovascular Interventions · 2025-07 · 106 (1) · 530-539
DOI: 10.1002/ccd.31571 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 09.05.2025. Verfasst von Matteo Rocchetti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Cardio-Thoracic Department, San Carlo Borromeo Hospital (ASST Santi Paolo e Carlo), Milan, Italy. Hauptthemen laut MEDLINE: Coronary Artery Disease, Coated Materials, Biocompatible, Cardiac Catheters, Angioplasty, Balloon, Coronary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Coronary bifurcation lesions (CBL) account for ~20% of percutaneous coronary interventions (PCI). When using provisional stenting, optimal management of a diseased side branch (SB) remains debated. Drug‐coated balloons (DCBs) are an emerging option, but data on their role in CBL PCI are limited.
Aims
We conducted a meta‐analysis to compare DCBs and non‐compliant balloons (NCBs) for SB treatment.
Methods
A systematic search of MEDLINE, CENTRAL, and EmBase (until November 2024) identified studies comparing DCBs and NCBs for treating the SB. From 1451 studies, five were included (two randomized controlled trials [RCTs], three observational), with 1762 patients, predominantly male with acute coronary syndrome (ACS). The primary outcome was major adverse cardiac events (MACE); secondary outcomes included myocardial infarction (MI), target lesion revascularization (TLR), and target vessel revascularization (TVR).
Results
DCBs significantly reduced MACE (pooled OR 0.48, 95% CI 0.34–0.68, p < 0.0001, I ² = 0%) and MI (pooled OR 0.39, 95% CI 0.25–0.62, p < 0.001, I ² = 0%) compared to NCBs. No significant differences were observed in TLR or TVR. Subgroup analysis confirmed consistency across observational studies and RCTs for MACE and MI.
Conclusions
DCBs in SB treatment during CBL PCI are associated with reduced MACE and MI compared to NCBs, with no significant differences in vessel‐specific outcomes. These findings suggest a potential clinical benefit of DCBs in reducing ischemic events, while limiting stenting in CBL. Further research is needed to refine patient selection and optimize outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Cardio-Thoracic Department, San Carlo Borromeo Hospital (ASST Santi Paolo e Carlo), Milan, Italy.
- University of Milan, Milan, Italy.
ORCID-Profile: Matteo Rocchetti
Zitieren
APA
Rocchetti, M., Tua, L., Cereda, A., Conconi, B., Gabriele Franchina, A., Carlà, M., Spangaro, A., & Lucreziotti, S. (2025). Drug‐Coated Balloons Versus Non‐Coated Balloons for Side Branch Treatment in Bifurcation Lesions: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions, 106(1), 530-539. https://doi.org/10.1002/ccd.31571
Vancouver
Rocchetti M, Tua L, Cereda A, Conconi B, Gabriele Franchina A, Carlà M, et al. Drug‐Coated Balloons Versus Non‐Coated Balloons for Side Branch Treatment in Bifurcation Lesions: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. 2025;106(1):530-539. doi:10.1002/ccd.31571
BibTeX
@article{Rocchetti2025,
author = {Rocchetti, Matteo and Tua, Lorenzo and Cereda, Alberto and Conconi, Barbara and Gabriele Franchina, A and Carlà, Matteo and Spangaro, Andrea and Lucreziotti, Stefano},
title = {Drug‐Coated Balloons Versus Non‐Coated Balloons for Side Branch Treatment in Bifurcation Lesions: A Systematic Review and Meta‐Analysis},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
volume = {106},
number = {1},
pages = {530--539},
doi = {10.1002/ccd.31571}
}
EUVIMED